Tectonic Therapeutic (TECX) News Today $47.53 +3.01 (+6.76%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Tectonic Therapeutic (NASDAQ:TECX) Shares Up 5.5% - Still a Buy?Tectonic Therapeutic (NASDAQ:TECX) Trading Up 5.5% - Should You Buy?December 17 at 4:24 PM | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) have earned a consensus recommendation of "Buy" from the six research firms that are currently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and one has given a strong buy recomDecember 15 at 6:15 AM | marketbeat.comFmr LLC Has $36.97 Million Holdings in Tectonic Therapeutic (NASDAQ:TECX)Fmr LLC increased its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 13.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,220,138 shares of the company's stock afterDecember 9, 2024 | marketbeat.comVerition Fund Management LLC Cuts Stake in Tectonic Therapeutic (NASDAQ:TECX)Verition Fund Management LLC lowered its position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 18.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 114,778 shares of the company's stock aDecember 4, 2024 | marketbeat.comWalleye Capital LLC Has $2.21 Million Position in Tectonic Therapeutic (NASDAQ:TECX)Walleye Capital LLC grew its position in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 204.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 72,962 shares of the company's stock after purchasing an additional 48,978 shares durinDecember 4, 2024 | marketbeat.comTectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024December 3, 2024 | globenewswire.comAcuta Capital Partners LLC Takes $415,000 Position in Tectonic Therapeutic (NASDAQ:TECX)Acuta Capital Partners LLC acquired a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 13,700 shares of the company's stock, valuedNovember 28, 2024 | marketbeat.comTectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare ConferenceNovember 26, 2024 | globenewswire.comRaymond James Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform RecommendationNovember 22, 2024 | msn.comTectonic Therapeutic initiated with an Outperform at Raymond JamesNovember 20, 2024 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Earns Outperform Rating from Analysts at Raymond JamesRaymond James began coverage on Tectonic Therapeutic in a research report on Wednesday. They issued an "outperform" rating and a $65.00 price target for the company.November 20, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year High on Analyst UpgradeTectonic Therapeutic (NASDAQ:TECX) Sets New 12-Month High Following Analyst UpgradeNovember 13, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) is BML Capital Management LLC's 7th Largest PositionBML Capital Management LLC lowered its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 54.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 211,752 shares of the company's stock after selling 254,295 shares during the peNovember 12, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up on Analyst UpgradeTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst UpgradeNovember 12, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $79.00Wells Fargo & Company boosted their price objective on shares of Tectonic Therapeutic from $55.00 to $79.00 and gave the company an "overweight" rating in a research note on Tuesday.November 12, 2024 | marketbeat.comTectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion ProteinNovember 11, 2024 | globenewswire.comInsiders Pour Million-Plus Dollars into These 2 Stocks — Here’s Why You Should Take NoticeNovember 8, 2024 | msn.comTectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - What's Next?November 7, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - Here's What HappenedNovember 1, 2024 | marketbeat.comTectonic Therapeutic Independent Director Acquires 7.0% More StockOctober 29, 2024 | finance.yahoo.comInsider Purchase: Director at Tectonic Therapeutic (TECX) Buys 300,000 SharesOctober 25, 2024 | quiverquant.comTectonic Therapeutic (NASDAQ:TECX) Sets New 12-Month High After Insider Buying ActivityTectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High on Insider Buying ActivityOctober 25, 2024 | marketbeat.comInsider Buying: Tectonic Therapeutic (NASDAQ:TECX) Director Purchases 300,000 Shares of StockOctober 25, 2024 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in StockTectonic Therapeutic (NASDAQ:TECX - Get Free Report) Director Timothy A. Springer purchased 300,000 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were acquired at an average price of $33.59 per share, for a total transaction of $10,077,000.00. Following the completion of the transaction, the director now directly owns 4,096,764 shares of the company's stock, valued at $137,610,302.76. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.October 24, 2024 | marketbeat.comTectonic Therapeutic to Present Phase 1a Data at AHA 2024October 22, 2024 | globenewswire.comTectonic Therapeutic: Interesting CV Disease Drug DeveloperOctober 20, 2024 | seekingalpha.comTectonic Therapeutic, Inc. (TECX)October 20, 2024 | finance.yahoo.comTectonic Therapeutic (NASDAQ:TECX) Reaches New 1-Year High - Time to Buy?Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week High - Here's WhyOctober 15, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sees Unusually-High Trading Volume - Still a Buy?Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - Here's What HappenedOctober 14, 2024 | marketbeat.comShort Interest in Tectonic Therapeutic (NASDAQ:TECX) Increases By 258.0%Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 303,900 shares, an increase of 258.0% from the September 15th total of 84,900 shares. Approximately 3.9% of the shares of the stock are sold short. Based on an average trading volume of 72,400 shares, the short-interest ratio is presently 4.2 days.October 10, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Down 4.5% - Time to Sell?Tectonic Therapeutic (NASDAQ:TECX) Trading Down 4.5% - Here's WhyOctober 9, 2024 | marketbeat.comVida Ventures Advisors LLC Takes Position in Tectonic Therapeutic (NASDAQ:TECX)Vida Ventures Advisors LLC bought a new stake in Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,028,674 shares of the company's stock, valued at approximOctober 9, 2024 | marketbeat.com89,029 Shares in Tectonic Therapeutic (NASDAQ:TECX) Acquired by Renaissance Technologies LLCRenaissance Technologies LLC purchased a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 89,029 shares of the company's stock, valued atOctober 5, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year High - What's Next?October 4, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Up 5.8%Tectonic Therapeutic (NASDAQ:TECX) Shares Up 5.8%October 2, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Trading Down 7%Tectonic Therapeutic (NASDAQ:TECX) Trading Down 7%October 1, 2024 | marketbeat.comTectonic Therapeutic director buys shares worth over $1.4 millionSeptember 28, 2024 | investing.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $1,441,000.00 in StockSeptember 27, 2024 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Short Interest UpdateTectonic Therapeutic (NASDAQ:TECX - Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 84,900 shares, a growth of 166.1% from the August 31st total of 31,900 shares. Approximately 0.7% of the shares of the stock are short sold. Based on an average trading volume of 47,000 shares, the short-interest ratio is presently 1.8 days.September 26, 2024 | marketbeat.comAffinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX)Affinity Asset Advisors LLC purchased a new stake in Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 58,331 shares of the company's stock, valued at approximateSeptember 25, 2024 | marketbeat.comFarallon Capital Management LLC Makes New $7.10 Million Investment in Tectonic Therapeutic (NASDAQ:TECX)Farallon Capital Management LLC purchased a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 431,010 shares of the company's stock, valued at approxSeptember 24, 2024 | marketbeat.comNxera Pharma Co., Ltd. (4565.T) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comTectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth PlansSeptember 23, 2024 | finance.yahoo.comTD Cowen Reaffirms Their Buy Rating on Tectonic Therapeutic (TECX)September 21, 2024 | markets.businessinsider.comPiper Sandler Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)September 21, 2024 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Sees Large Volume IncreaseTectonic Therapeutic (NASDAQ:TECX) Sees Strong Trading VolumeSeptember 20, 2024 | marketbeat.comTectonic Therapeutics Announces Positive Phase 1a Results For TX45 In Treating Group 2 PH-HFpEFSeptember 20, 2024 | markets.businessinsider.comTectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45September 19, 2024 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9%Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9%September 17, 2024 | marketbeat.comAtlas Venture Life Science Advisors LLC Buys New Stake in Tectonic Therapeutic (NASDAQ:TECX)Atlas Venture Life Science Advisors LLC purchased a new position in Tectonic Therapeutic (NASDAQ:TECX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 378,447 shares of the company's stock, valuSeptember 15, 2024 | marketbeat.com Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address How this >10-cent coin is going to outperform Bitcoin (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2024 TECX Media Mentions By Week TECX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECX News Sentiment▼1.430.72▲Average Medical News Sentiment TECX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECX Articles This Week▼23▲TECX Articles Average Week Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arrowhead Pharmaceuticals News Today MorphoSys News Today Kymera Therapeutics News Today Edgewise Therapeutics News Today Gemini Therapeutics News Today Vericel News Today Keros Therapeutics News Today Iovance Biotherapeutics News Today Agios Pharmaceuticals News Today Catalyst Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
